Biohaven Pharmaceuticals has announced that it has developed a vaccine against the deadly respiratory illness tuberculosis that affects more than a million people in Australia each year.The company has also developed a new lung-protection device to stop the spread of the disease.Dr Peter Whelan, president and chief executive officer of Biohaven, said the vaccine was […]

Continue Reading...